Clinical Trial

Clinical Trial to Evaluate the Efficacy and Safety of Nexpowder™ for Diverticular Bleeding in the Lower Gastrointestinal Tract

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Clinical Trial to Evaluate the Efficacy and Safety of Nexpowder™ for Diverticular Bleeding in the Lower Gastrointestinal Tract
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-18.
Trial Details
NCT Number NCT06939907
Lead Sponsor Next Biomedical Co., Ltd.
Conditions Lower Gastrointestinal Bleeding, Diverticular Bleeding
Enrollment 60 participants
Start Date 2025-06
Primary Completion 2027-06 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2025-04-25